Quick Answer
INOVIO PHARMACEUTICALS, INC. reported Shares Outstanding of 69.00 million shares for fiscal year 2025.
INOVIO PHARMACEUTICALS, INC. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 69.00M | +91.1% |
| 2024 | 36.10M | +58.4% |
| 2023 | 22.79M | +8.1% |
| 2022 | 21.09M | -90.3% |
| 2021 | 217.38M | +16.3% |
| 2020 | 186.85M | +84.3% |
| 2019 | 101.36M | +4.3% |
| 2018 | 97.23M | +7.6% |
| 2017 | 90.36M | +22.0% |
| 2016 | 74.06M | +2.6% |
| 2015 | 72.22M | +18.9% |
| 2014 | 60.74M | +15.5% |
| 2013 | 52.58M | -63.6% |
| 2012 | 144.31M | +6.9% |
| 2011 | 134.97M | +28.5% |
| 2010 | 105.04M | — |
- INOVIO PHARMACEUTICALS, INC. showed an increase of +91.1% in Shares Outstanding compared to the prior fiscal year.
- Over the 2010–2025 period, INOVIO PHARMACEUTICALS, INC.’s shares outstanding has declined by 34.3% (from 105.04 million shares to 69.00 million shares).
- The most recent figure is from INOVIO PHARMACEUTICALS, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: